Literature DB >> 19946968

Cancer pain--progress and ongoing issues in New Zealand.

W J Landman1, B A Foggo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946968      PMCID: PMC3958383     

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


× No keyword cloud information.
  8 in total

Review 1.  Treatment of temporal variations in chronic cancer pain.

Authors:  R K Portenoy
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

2.  Breakthrough pain: characteristics and impact in patients with cancer pain.

Authors:  R K Portenoy; D Payne; P Jacobsen
Journal:  Pain       Date:  1999-05       Impact factor: 6.961

Review 3.  Management of breakthrough pain in patients with cancer.

Authors:  Leeroy William; Rod Macleod
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  A survey of symptoms in hospice patients in Singapore.

Authors:  W K Tay; R J Shaw; C R Goh
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

5.  Pain, opioid use, and survival in hospitalized patients with advanced cancer.

Authors:  F J Brescia; R K Portenoy; M Ryan; L Krasnoff; G Gray
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

6.  Description and predictors of direct and indirect costs of pain reported by cancer patients.

Authors:  Barry V Fortner; Gail Demarco; Gordon Irving; Jeri Ashley; Ginny Keppler; Jana Chavez; Jana Munk
Journal:  J Pain Symptom Manage       Date:  2003-01       Impact factor: 3.612

7.  The symptoms of advanced cancer.

Authors:  S Donnelly; D Walsh
Journal:  Semin Oncol       Date:  1995-04       Impact factor: 4.929

8.  A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain.

Authors:  Barry V Fortner; Theodore A Okon; Russell K Portenoy
Journal:  J Pain       Date:  2002-02       Impact factor: 5.820

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.